Senin and colleagues described the association between SF3B1 mutations and PV progression to MF [37]; conversely, Tefferi and colleagues did not confirm this result, but they correlated SF3B1 mutations with decreased myelofibrosis-free survival in ET patients [38]. Here, SF3B1 is linked to acquired polycythemia vera.